Birchview Capital, LP Portfolio Holdings

Birchview Capital, LP

  • $111 Million
  • Q1 2025

Birchview Capital, LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $111 Million distributed in 68 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bristol Myers Squibb CO with a value of $41.8M, Corcept Therapeutics Inc with a value of $7.54M, Acadia Pharmaceuticals Inc with a value of $4.38M, Prothena Corp Public LTD CO with a value of $4.12M, and Biodesix Inc with a value of $3.61M.

Examining the 13F form we can see an decrease of $6.13M in the current position value, from $117M to 111M.

Birchview Capital, LP is based out at Burlington, VT

Below you can find more details about Birchview Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $111 Million
Healthcare: $106 Million
Energy: $4.08 Million
ETFs: $1.17 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$0
$1.17 Million 1.05% of portfolio
20,000
Q4 2024 Reduced 10.0%

Summary

  • Portfolio
  • No. of Stocks 68
  • Current Value $111 Million
  • Prior Value $117 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 4 stocks
  • Additional Purchases 21 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email